Search

Home > Orthopedics This Week > Will a $95 Million Deal Bring Chemonucleolysis Back?
Podcast: Orthopedics This Week
Episode:

Will a $95 Million Deal Bring Chemonucleolysis Back?
Category: Science & Medicine
Duration: 00:06:02
Publish Date: 2016-10-19 08:28:46
Description:

Is chemonucleolysis for painful lower back disc herniation returning? In the 1980s chymopapain achieved fairly wide spread use as a chemonucleolysis agent. Outcomes were highly technique and patient selection dependent. It eventually left the market. Now two large firms have inked a deal to bring a new chemonucleolysis approach to market. Will this one work?
Total Play: 0